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Abstract
Background: Endochondral ossification is a complex process involving a series of events that are initiated by the
establishment of a chondrogenic template and culminate in its replacement through the coordinated activity of osteoblasts,
osteoclasts and endothelial cells. Comprehensive analyses of in vivo gene expression profiles during these processes are
essential to obtain a complete understanding of the regulatory mechanisms involved.
Methodology/Principal Findings: To address these issues, we completed a microarray screen of three zones derived from
manually segmented embryonic mouse tibiae. Classification of genes differentially expressed between each respective
zone, functional categorization as well as characterization of gene expression patterns, cytogenetic loci, signaling pathways
and functional motifs both confirmed reported data and provided novel insights into endochondral ossification. Parallel
comparisons of the microdissected tibiae data set with our previously completed micromass culture screen further
corroborated the suitability of micromass cultures for modeling gene expression in chondrocyte development. The
micromass culture system demonstrated striking similarities to the in vivo microdissected tibiae screen; however, the
micromass system was unable to accurately distinguish gene expression differences in the hypertrophic and mineralized
zones of the tibia.
Conclusions/Significance: These studies allow us to better understand gene expression patterns in the growth plate and
endochondral bones and provide an important technical resource for comparison of gene expression in diseased or
experimentally-manipulated cartilages. Ultimately, this work will help to define the genomic context in which genes are
expressed in long bones and to understand physiological and pathological ossification.
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zone and is populated with actively dividing chondrocytes
arranged in characteristic columns of disc-shaped cells. Upon
completion of the proliferative period, chondrocytes mature to
hypertrophic chondrocytes, which, as their name suggests, are
enlarged cells that constitute the hypertrophic zone. When
chondrocytes terminally differentiate, they undergo apoptosis,
leaving behind a calcified extracellular matrix (ECM) that is
remodeled and degraded by invading blood vessels, osteoprogenitor cells and bone-resorbing cells. This coordinated developmental
process of chondrocyte proliferation and differentiation is
ultimately responsible for longitudinal bone growth and the final
length of mature bone.
During early postnatal life, areas of secondary ossification form
in the epiphyseal ends of the long bones. Similarly to the process
of primary ossification described above, this process consists
of chondrocyte hypertrophy, mineralization, vascular invasion
and ultimately replacement of cartilage by bone. The growth

Introduction
Endochondral ossification (EO) is the process through which the
axial and appendicular skeletal elements form via a transient
cartilaginous intermediate [1,2]. The development of temporary
cartilage involves the differentiation of mesenchymal precursor
cells along the chondrogenic lineage. The different stages of this
developmental program occur in a well-defined region, known as
the growth plate [3]. In the growth plate, chondrocytes progress
through each step of their life cycle in a spatial pattern where cell
morphology correlates with the temporal progression of chondrocyte maturation. The region nearest to the end of the bone is the
outermost growth plate zone or resting zone. Chondrocytes in this
zone appear small and rounded and likely provide the cellular pool
for both future articular chondrocytes and chondrocytes undergoing the subsequent stages of growth plate differentiation. The
proliferative zone of the growth plate lies adjacent to the resting
PLoS ONE | www.plosone.org
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plate persists between primary and secondary ossification center
and continues to direct longitudinal growth of endochondral
bones.
Numerous molecular markers characterize the central stages of
the chondrocyte life cycle. Chondrogenesis is typified by the
expression of Sox transcription factors 5,6 and 9 [1,4].
Proliferating chondrocytes synthesize an ECM composed mainly
of collagen II and aggrecan, among others, while the central ECM
molecule expressed in hypertrophic cartilage is collagen X [5].
Factors expressed at the chondro-osseous junction regulate
chondrocyte apoptosis and mineralization of the cartilaginous
ECM. Late hypertrophic chondrocytes express factors that
promote angiogenesis, bone deposition and the secretion of
bone-specific cell ECM. These factors include Vegf (vascular
endothelial growth factor), Mmp13(matrix metalloproteinase 13),
Mmp9 and Ibsp [6–12]. Additional markers of the osteoblast and
osteoclast phenotype, including core-binding factor alpha 1/runtrelated transcription factor 2 (Cbfa1/Runx2), acid phosphatase 5,
tartrate resistant (Acp5) and tumor necrosis factor (ligand)
superfamily, member 11 (Tnfsf11; RANKL/receptor activator of
NF-kappaB ligand) are upregulated in hypertrophic cartilage and
cells in the zone of ossification [13,14].
Generally, gene expression in growth plate chondrocytes is
studied by immunohistochemistry, in situ hybridization or by
isolating cells from various sources including cell lines and primary
cell cultures; however, only a few studies have quantified global
gene expression in the context of the whole growth plate or as a
function of its constituent zones. Studies typically investigate gene
expression by using cell lines [15–17], isolated early-stage limb
mesenchyme [18], whole growth plates [19], or laser-capture
microdissection, which requires fixation and decalcification
protocols, and sectioning to evaluate gene expression in specific
regions of the growth plate [20–23]. While all of these approaches
have yielded important insights, each suffers from some disadvantages. Currently used in vitro approaches have been instrumental in
the systematic characterization of both general growth plate trends
and the expression of genes in different cell populations of the
growth plate, but the physiological context is at times compromised by experimental manipulation. Several studies have
investigated the effects of such manipulations on gene expression
in chondrocytes and attempted to preserve tissue structure and
gene expression [24–27]. Cell culture models are, however, limited
in their ability to maintain the physiological cell-cell and cellmatrix interactions occurring in the intact growth plate. Similarly,
the micromass culture system, which is able to better recapitulate
the three-dimensional context of chondrocyte differentiation,
suffers from other unfavorable factors such as cellular heterogeneity and the effects of enzymatically disrupting cells and the
absence of spatial architecture. The advent of laser capture
microdissection permitted the isolation of individual cell populations directly from the growth plate, but can produce spurious
results since tissue processing affects tissue integrity and can alter
the detection of some expressed genes [24,28]. In addition, no
microarray studies on laser capture microdissection of prenatal
mouse cartilage have been described to our knowledge.
Consequently, the objectives of the current study were threefold: 1. to examine differential gene expression between different
zones of embryonic tibiae using manual microdissection; 2. to
identify key functional categories associated with individual zones;
3. to evaluate this system in the context of our previously used
micromass culture system [29]. This will provide an in-depth
assessment of the suitability of three-dimensional cell culture
models for temporal and spatial gene expression patterns in
cartilage.
PLoS ONE | www.plosone.org

Methods
Ethics Statement
All animal studies were approved by the Animal Use
Subcommittee of the Council of Animal Care at the University
at Western Ontario.

Animals and Manual Growth Plate Microdissection
Tibiae derived from four litters of CD1 mice (Charles River)
staged at embryonic day 15.5 (E15.5) were isolated and manually
separated into three segments based on morphological criteria
(Figure 1A, left panel); each litter represented one independent
experiment. Starting at either extremity, the region corresponding
to approximately the first third of the bone was segmented and
designated zone I, which contains both proliferating and resting
cells. The next zone corresponding to the second third of the bone
was named Zone II and contains mostly prehypertrophic and
hypertrophic chondrocytes. The final zone, zone III, constitutes
both the most mature hypertrophic chondrocytes and the
mineralized portion of the tibiae.

RNA Isolation, Microarray Analysis and Quantitative
Real-Time Polymerase Chain Reaction
Growth plate segments from zone I, II and III were pooled for all
animals within one litter. Total RNA was immediately isolated using
Qiazol lysis reagent and RNEasy Mini Kit columns (Qiagen)
according to the manufacturer’s protocol as described [30,31] RNA
quantity and integrity was assessed using the RiboGreen RNA
Quantitation Kit (Molecular Probes), and samples were processed
and hybridized to the Affymetrix MOE430 2.0 mouse genome chips
at the London Regional Genomics Facility. All data is MIAME
compliant and the raw data has been deposited in a MIAME
compliant database (GEO). The microdissected microarray data set
is archived in the gene expression omnibus repository (GEO
accession: GSE7685). Quantitative real-time polymerase chain
reaction (qRT-PCR) amplification was completed using the ABI
Prism 7900 Sequence Detection System (Applied Biosystems).
Triplicate reactions were executed for each sample of each of four
independent trials. TaqMan one-step master mix kit (Applied
Biosystems) and gene-specific target primers and probes were used
for amplification. TaqMan GAPDH control reagents for housekeeping gene Glyceraldehyde-3-phosphate dehydrogenase (Gapdh,
forward primer 59-GAAGGTGAAGGTCGGAGTC; reverse
primer 59-GAAGATGGTGATGGGATTTC; probe JOE-CAAGCTTCCCGTTCTCAGCC-TAMRA) were used as an internal
amplification control. Integrin-binding sialoprotein (Ibsp), dentin
matrix protein (Dmp1), cyclin-dependent kinase 1c, (Cdkn1c), Col2a1,
Indian hedgehog (Ihh) and Sox9 were assayed using the TaqManH
gene expression assays in accordance with the manufacturer’s
directions. Amplified transcripts were quantified using the standard
curve method, and the relative transcript abundance was
determined by calculating the quotient of the gene of interest and
equivalent Gapdh values. Fold changes in expression were calculated
relative to zone I. Statistical significance was determined by oneway ANOVA analysis and a Bonferroni’s multiple comparison Test.
P-values less than 0.05 were deemed significant.

Data Analysis
Microarray data was pre-processed using the GC (guanine and
cytosine) Robust Multi-chip Averaging (RMA) algorithm in
Genespring GX*. Expression values were further filtered by
retaining only those probe sets with expression values of at least 50
in at least 25% of all conditions, thus generating a list of 22 497
probe sets. Subsequent zone comparisons from the microdissected
2
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Figure 1. Tibia microdissection and microarray analysis of microdissected zones. Tibiae from 15.5 day old mouse embryos were dissected
into three segments called zones I, II and III. Striated lines indicate location of manual segmentation (A, left panel). Growth plate segments for each zone
were pooled and total RNA was isolated and hybridized to Affymetrix MOE 430 2.0 chips containing 45 101 probe sets. This experiment was repeated in
quadruplicate (A, right panel). Red lines denote probe sets with increased expression in zone I relative to the baseline signal intensity and blue lines
denote probe sets that are decreased relative to the baseline signal intensity. White lines represent genes expressed near the baseline intensity. Growth
plate microdissection reveals expected expression profiles for established markers of endochondral bone formation. (B) Microarray expression profiles
for chondrocyte differentiation sox family members 5, 6 and 9, (Sox- 5, 6 and 9), collagen 2 (Col2a1), growth differentiation factor 5 (Gdf5), aggrecan 1
(Agc 1), collagen XI alpha 1 (Col11a1), hyaluronan and proteoglycan link protein 1 or cartilage link protein 1(Hapln1), fibroblast growth factor receptor 3
(Fgfr3) and collagen IX alpha 2 (col9a2) are shown (top panel). Late-stage markers of endochondral ossification exhibiting large increases in gene
expression in zone III include collagen X (Col10a1), matrix metalloproteinase 13 (Mmp13), matrix -metalloproteinase 9 (Mmp9), tumor necrosis factor
(ligand) superfamily, member 11 or receptor activator of NF-kappaB ligand (Tnfsf11), acid phosphatase 5, tartrate resistant (Acp5), integrin binding
sialoprotein (Ibsp), dentin matrix protein (Dmp1) and osteopontin (Spp1) (bottom left panel). Expression profiles for later stage markers that exhibit more
moderate increases in zone III included colony stimulating factor 1 (Csf1), runt related transcription factor 2 (Runx2), osteomodulin (Omd), a disintegrinlike and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4 and 5 (Adamts4, Adamts5) (panel, right panel).
doi:10.1371/journal.pone.0008693.g001

discarding poorly expressed probe sets, a list of 13 185 probe sets
was obtained. Additionally, analogous comparisons involved day 3
vs. 9, day 9 vs. 15 and day 3 vs. 15 lists which contained 3828,
2005 and 5580 probe sets, respectively, upon being filtered using a
1.5-fold change filter (Table 2).

tibiae data set (MD) were filtered using a 1.5-fold change threshold
that produced lists of 6185, 8134 and 7220 probe sets for the zone
I vs. II, II vs. III and zone I vs. III, respectively (Table 1).
The same data set was normalized in parallel using RMA using
RMAEXPRESS software v.0.4.1 developed by B. Bolstad,
University of California, Berkeley [32]. Background adjustment
and quantile normalization parameters were selected for data
processing. Logarithmically transformed expression values were
used to implement Gene Set Enrichment Analysis (GSEA).
The micromass culture data set (MM) [29] (GEO accession:
GSE2154) was similarly processed for comparative studies. After
PLoS ONE | www.plosone.org

Gene Ontology Annotations
Probe set lists composed of I vs. II, II vs. III and I vs. III zone
comparisons exhibiting at least 1.5-fold changes in gene expression
between each respective condition were used as inputs for
Genespring GX Gene Ontology annotations.
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calculated for a priori gene lists or gene sets that are associated with
a particular molecular classification. In our analysis, gene sets were
created from different functional groupings, molecular classifications, tissues, and other microarray screens [35]. Ranked
enrichment scores (RES) that determine the extent to which
individual genes from a gene set are represented at the extremes of
the ranked gene list are then calculated. Specifically, these values
are obtained by walking along the ranked list using a cumulative
sum statistic which increases when a member of a particular gene
set is found in the ranked gene list and zone and is coordinately
penalized when it does not appear in the gene set. A null
distribution of ES is subsequently generated by permutation
filtering to evaluate the statistical significance of the observed RES
values. Permutation filtering randomly assigns the experimental
conditions or class labels (i.e., I vs. II) to the different microarray
samples. After this procedure has been repeated for each gene set,
the ES are normalized (NES) to account for differences in gene set
size. The false discovery rate (FDR) is then calculated relative to
the NES values to determine the false-positive rate. Significant
FDR and p-values were defined as less than 25% and 0.001,
respectively, in accordance with GSEA recommendations.

Table 1. Microarray analysis of microdissected embryonic
growth plates.

Specifications

Probe sets
I vs. II

Probe sets
II vs. III

Probe sets
I vs. III

Total number of probe sets

45101

45101

45101

Significantly expressed

22497

22497

22497

1.5 fold change

6185

8134

7220

5 fold change

474

937

766

10 fold change

170

366

288

1.5 fold upregulated

3433

4005

3678

5 fold upregulated

317

262

305

10 fold upregulated

102

87

115

1.5 fold downregulated

2752

4129

3542

5 fold downregulated

157

675

461

10 fold downregulated

68

279

173

doi:10.1371/journal.pone.0008693.t001

Gene Set Enrichment Analysis (GSEA)

Gene Set Creation

The GSEA algorithm was implemented with GSEA v2.0
software [33,34]. Ranked expression lists were derived from
RMAEXPRESS and GeneSpring GXH 7.3.1. Briefly, the GSEA
algorithm ranks all array genes according to their expression under
each experimental condition. The resulting ranked metric score
(RMS) is therefore a function of the correlation between a gene’s
signal intensity, the experimental conditions in question and all
other genes in the data set. Enrichment score (ES) are then

User defined gene sets. Gene sets were generated using the
probe set search tool and the molecular function class of Gene
Ontology annotations in GeneSpring GX. Additional gene sets
were created using lists from pair-wise comparisons between day 3
and 9, day 9 and 15 and day 3 and 15 of a previously generated
micromass data set ([29], Table 3). A total of 3828, 2005, 5183
probe sets showing a minimum 1.5-fold change in gene expression
were used for the 3 vs. 9, 9 vs. 15 and 3 vs. 15 lists. Probe set
redundancy was eliminated in all gene sets using the
CollapseDataset function in the GSEA program. All probe set
identifiers were converted to the Human Genome Organization
(HUGO) annotations. Probe sets lacking corresponding HUGO
annotations were excluded from the analysis. Default parameters
were used to execute the analysis and median values taken to
represent the range of duplicated probe sets for a given gene. A total
of 90 user-defined gene sets were generated from GeneSpringderived annotations for various molecular classifications.
Gene sets from the Molecular Signature Database. To
provide an unbiased assessment of the similarities between the
micromass (MM) and microdissected (MD) data sets, enrichment
of specific cytogenetic loci, molecular pathways and regulatory
motifs in different zones of the growth plate, we used the GSEA
algorithm in combination with gene sets available from the GSEA
Molecular Signature Database (MgSigDB) (http://www.broad.
mit.edu/cancer/software/gsea/msigdb/msigdb_index.html). The
c1 = chromosomal location, c2 = functional, c3 = motifs gene sets
were used. Specifically, the c1 is composed of 325 gene sets
containing information about the cytogenetic locations of HUGO
and Unigene annotated genes. The c2 data set is a curated, 1137
gene set matrix containing information about specific biological,
metabolic and signaling pathways as gene ontologies, chemical
and genetic perturbations, disease phenotypes and animal models.
Microarray screens published in the biomedical literature were
additionally included in the c2 gene set. The c3 matrix contained
173 gene sets containing functional motifs conserved in the
human, mouse, rat and dog genomes including putative
transcription factor binding sites from TRANSFAC, a
transcription factor binding site search program and data base,
candidate motifs and microRNA target sequences. Results with a
p,0.001 and FDR,0.25 are shown.

Table 2. Comparisons between microdissected and
micromass arrays.

Classifications

Probe set number

Total number of probe sets

45101

Probe sets expressed in MD*

22497

Probe set expressed in MM**

13185

Probe sets common to both lists

11806

Probe sets only found in MM

1379

Probe sets only found in MD

10691

Probe sets in 3 vs. 9

3828

Probe sets in 9 vs. 15

2005

Probe set in 3 vs. 5

5580

Probe sets found in 3 vs. 9 AND I vs. II

1323

Probe sets found only in 3 vs. 9

2505

Probe sets found only in I vs. II

4862

Probe sets found in 9 vs. 15 AND II vs. III

886

Probe sets found only in 9 vs. 15

1119

Probe sets found only in II vs. III

7248

Probe sets found in 3 vs. 15 AND I vs. III

2037

Probe sets found only in 3 vs. 15

3543

Probe sets found only in I vs. III

5183

note: fold changes include genes that are both up and downregulated.
*
microdissected tibiae data set.
**
micromass culture data set.
doi:10.1371/journal.pone.0008693.t002
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Results and Discussion

Table 3. Gene sets used in GSEA.

Category name

Number of
genes

Category name

Number of
genes

Adipose

70

Fkbp

33

Apoptosis

39

Igf

48

Bone

116

Cart 2

299

Cartilage

28

Cart 3

352

Catalytic

245

Liver 1

260

Chaperone

81

Liver 2

260

Chemokine

31

Blood

111

Chromatin Hdac

24

Protease 1

269

Cyclin

225

Protease 2

269

Cytokine

127

Phosphatase

473

1 Dnabind

500

Dusp

20

2 Dnabind

448

Kinase 1

499

Ecm

228

Kinase 2

499

Electron Transp

40

Kinase 3

227

Gf Receptor

327

Integrin Rel

173

Gluconeogen

31

Brain Rel

379

Growth Factor

106

Hepatocyte

19

Gtpase Activator

46

Obl Oclast

16

Gtpase Activ

73

Interleukinrelated

175
44

Heparin Bind

37

Rgs Related

Hormone

75

Caspase Related

47

Muscle

198

Creb Atf3

32

Neg Apoptosis

50

Nuclear Receptor

138

Oncogene

154

Nuc Hormone Receptor

55

Pos Apoptosis

79

Pzhorton.Farnum

413

Related Apoptosis

311

Hzhorton.Farnum

407

Structure

151

3 vs. 9 1

495

Sugar Bind

104

3 vs. 9 2

495

Tf Activ

56

3 vs. 9 3

495

Tf Repress

55

3 vs. 9 4

495

Tgfb

45

3 vs. 9 5

495

Tnf Receptor

69

3 vs. 9 6

276

Tumor Suppressor

48

9 vs. 15 1

497

Wnt

53

9 vs. 15 2

497

Actin Cytoskel

38

9 vs.15 3

497

Angiogen

57

9 vs. 15 4

39

Bmprelated

62

3 vs. 15 1

497

Cytoplasm

411

3 vs. 15 2

497

Erk Related

40

3 vs. 15 3

497

Fgf Related

64

3 vs. 15 4

497

Membrane

260

3 vs. 15 6

497

Mapkrelated

267

3 vs. 15 5

497

Metabolism

196

3 vs. 15 7

497

Nucleus 1

494

3 vs. 15 8

462

Nucleus 2

494

Nucleus 3

510

Transcriptional Profiling of Embryonic Growth Plate
Zones and Data Validation
The embryonic tibia is composed of several morphologically
distinct zones that mirror the different phases of the chondrocyte
life cycle. To elucidate the correlation between morphological
differences in growth plate regions and their corresponding gene
expression patterns, we isolated tibiae from E15.5 day old mouse
embryos. Tibiae were manually divided into three zones
(Figure 1A, left panel). RNA samples from each zone were
subsequently isolated and hybridized to Affymetrix MOE 430 2.0
arrays for microarray analysis. Upon completion of all data
processing, we obtained a list of 22 497 probe sets expressed in at
least one zone (Table 1, Figure 1A, right panel).
To confirm the expression of established markers of endochondral ossification found in our array to the literature, we first
examined our microarray data sets for the expression of early stage
chondrocyte markers such as Sox family members 5,6 and 9
(Sox5,6 and 9), Col2a1, growth differentiation factor 5 (Gdf5), Agc 1,
Col11a1, Hapln1, Fgfr3 and Col9a2 (Figure 1B, top panel). Overall,
these markers exhibited expected and consistent expression
patterns in that higher expression occurred in zone I and lower
expression occurred in zone III. Zone II markers showed less
consistency in both the amplitude of the signal intensity and the
actual pattern of gene expression [4,36–40].
Expression of late stage chondrocyte markers such as Col10a1
and molecules involved in matrix turnover, EO, and osteoblast
and osteoclast differentiation were consistent with their expected
expression patterns [8,12–14,19,41–51]. Specifically, Mmp13,
Mmp9, Tnfsf11, Acp5, Ibsp, Dmp1, osteopontin (Spp1/Opn1), colony
stimulating factor 1 (Csf1), Cbfa1/Runx2, osteomodulin (Omd), a
disintegrin-like and metallopeptidase (reprolysin-type) with thrombospondin type 1 motif, -4 (Adamts4) and -5 (Adamts5) were all upregulated in zone III (Figure 1B, bottom). These data are
consistent with zone I corresponding to the resting and
proliferating chondrocytes, zone II consisting mostly of prehypertrophic and early hypertrophic chondrocytes, and zone III
consisting of late hypertrophic chondrocytes and possibly small
populations of invading osteoblasts, endothelial cells and osteoclasts.
In addition to confirming the expression of known markers by
comparing our microarray data to previously documented
findings, we verified transcript accumulation of selected factors
with qRT-PCR. We selected several known growth plate markers
including Sox9, Col2a1, Ihh and Cdkn1c (encoding the cell cycle
inhibitor p57). In accordance with the literature, Sox9 and Col2a1
expression was highest in zone I and zone II with lower expression
in zone III, which corresponds to the cartilage-bone interface
[52,53] (Figure 2). The correlation between microarray gene
expression profiles and qRT-PCR for these two markers was not,
however, exact, as we noticed decreased col2a1 expression in zone
II compared to Zone I in the qRT-PCR analysis (which is the
expected trend), while col2a1 expression was similar between these
2 zones in microarray data. This discrepancy warrants the use of
alternate techniques in addition to microarray analysis to precisely
quantify transcript and protein levels in each zone. In addition,
expression profiles for Ihh and Cdkn1c deviated from expected
patterns. In the case of Ihh, the microarray expression profile
demonstrated highest expression in zone II with lower expression
patterns in both zones I and III. Conversely, qRT-PCR
demonstrated that Ihh expression is maintained at higher levels
in zone III. Alternate confirmation with in situ hybridization and
immunohistochemistry is required to localize Ihh expression.

doi:10.1371/journal.pone.0008693.t003

PLoS ONE | www.plosone.org
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Figure 2. Real-time RT-PCR confirmation of early-stage markers of chondrocyte differentiation. Expression profiles of known
chondrocyte markers were evaluated with qRT-PCR. Zone-specific expression of SRY (sex determining region Y)-box 9 (Sox9), collagen 2 (Col2a1),
Indian hedgehog (Ihh) and cyclin-dependent kinase inhibitor 1c (Cdkn1c, encoding p57) profiles are shown on the right, with the corresponding
microarray data on the left. Four independent RNA isolations were evaluated for each probe and primer pair and p-values less than 0.05 were
deemed significant.
doi:10.1371/journal.pone.0008693.g002

between both methods, given the limitations of the normalization
algorithms used prior to assessing fold change differences [57].
Overall however, the trends of these results are consistent with the
time line for matrix turnover in EO in that remodeling of the
chondrocyte ECM follows hypertrophic differentiation [58,59].
Therefore, evaluation of gene expression patterns of prototypical
chondrocyte markers within different zones with qRT-PCR serves
as proof of concept for the utility of this system for studying relative
gene expression patterns.

These results indicate that microarray data for highly expressed
markers are consistent with the literature; however, genes with
lower gene expression levels exhibit greater variability. Cdkn1c is
expressed in post-mitotic cells of the growth plate [3,54,55] but we
did not find the anticipated trends between the zones. We were
able to establish differential Cdkn1c (p57) expression in zones I and
II of the growth plate with qRT-PCR (Figure 2) and immunostaining of embryonic growth plates for p57 protein [56]. The
presence of p57 immunostain in articular chondrocytes [56] could
account for the signal obtained for the resting/proliferating zone.
In parallel, we evaluated the expression patterns of late stage
ECM molecules including Col10a1, Ibsp and Dmp1 by qRT-PCR
(Figure 3). Ibsp and Dmp1 were expressed similarly in both assays in
which they exhibited increases in the range of 100- to 1000-fold in
zone III of the tibia. Col10a1 was an exception in that it exhibited a
lower fold change difference using qRT-PCR compared to the
microarray data. We expected a certain degree of variability
PLoS ONE | www.plosone.org

Functional Annotations of Microdissected Growth Plate
Gene Expression Patterns
To classify pervasive functional categories in endochondral
ossification, we created lists of pair-wise comparisons between the
different zones using a 1.5-fold change filter. The resulting lists
contained 6185, 8134 and 7220 probe sets for zone I vs. II (I vs.
II), zone II vs. III (II vs. III) and zone I vs. III (I vs. III)
6
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Figure 3. Real-time RT-PCR confirmation of later-stage markers of endochondral ossification. RNA samples from microdissected
embryonic tibiae were used to confirm microarray expression profiles for later-stage chondrocyte markers. Collagen X (Col10a1), bone sialoprotein
(Ibsp) and dentin matrix protein 1 (Dmp1) were identified in the microdissected array and validated with qRT-PCR. Four independent RNA isolations
were evaluated for each probe and primer pair and p-values less than 0.05 were deemed significant.
doi:10.1371/journal.pone.0008693.g003

all growth plate zones from our subsequent studies. We identified
1870 probe sets in zone intersections between all three pair-wise
comparisons, 2812 probe sets common to zones I vs. III and zone
II vs. III lists, 1511 probe sets common to the I vs. II and I vs. III
comparisons, and 1970 common to the I vs. II and II vs. III lists
(Figure 4B). We focused on classifying the 834, 1482, and 1027
probe sets that were unique to I vs. II, II vs. III and I vs. III
comparisons, respectively. For example, in the BP category, probe
sets involved in DNA replication, protein biosynthesis and gene
silencing were most significant in I vs. II, II vs. III and I vs. III
zone comparisons, respectively.. It is therefore likely that the
morphological differences in the embryonic tibia are mirrored, to
some extent, by zone-specific gene expression patterns; for
example, genes involved in protein synthesis exhibit larger changes
in the zone II vs. III comparison where cells undergo hypertrophic
cell growth.

comparisons, respectively (Table 1). We then overlapped these lists
with the biological process (BP), cellular component (CC) and
molecular function (MF) categories in the Gene Ontology browser
of GenespringGX (Figure 4A). Approximately 52% of all genes
contained in these lists have corresponding Gene Ontology
annotations. In each zone comparison, ‘‘development’’, ‘‘collagenous’’ probe sets and ‘‘molecular transport’’ were deemed the
most significant categories associated with BP, CC, and MF,
respectively (Figure 4A). Although the same general BP and CC
categories were identified in each zone comparison, the probe sets
making up these categories were not identical in each comparison
and only overlapped by 50%. The MF category did not contain
any similar probe sets. Therefore the categories of development,
collagen and transport genes were similarly prominent in lists of
genes changing among all growth plate zones, but the specific
genes belonging to these gene lists were not the same in the
different comparisons.
The identification of similar molecular categories irrespective of
the zone comparison evaluated emphasizes the concept of
networks and functional categories being responsible for regulating
the chondrocyte phenotype, rather than just individual genes. We
next endeavored to eliminate genes that exhibited changes among
PLoS ONE | www.plosone.org

Gene Expression Patterns in Growth Plate Zones
Our next objective was to identify molecular classes that were
enriched in the different growth plate zones by GSEA. GSEA
provides a means to describe how a gene list (e.g. the genes from a
zone I to II comparison) correlates positively or negatively with
7
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Comparisons between zones II and III revealed a similar trend
in which gene sets in zone II did not fulfill all criteria for significant
enrichment, while true enrichment in zone III was more extensive
(Table S2–1, see supplemental data). Cartilage genes, molecular
chaperones, metabolic genes and genes involved in gluconeogenesis were enriched in zone II (Table S2–2–5,-9, see supplemental
data). In zone III, genes sets containing molecules involved in
heparin binding, angiogenesis and chemokines, among others,
were enriched (Table S2–6–8, see supplemental data). Comparisons between zones I and III revealed no enrichment in zone I
(when considering the p-value threshold), but extensive enrichment in zone III with gene sets for blood, phosphatases, cartilage
and MAPK (Table S3–1–10, see supplemental data).
These results provided further evidence that genes regulating
endochdondral ossification present a combination of zone-specific
genes and broadly expressed genes. Cartilage gene sets were
significantly enriched in all zones; however, only the II vs. III and I
vs. III categories contained similar genes including Sox9, Hapln1
and Agc1 (Table S2–9, S3–11, see supplemental data). The
cartilage genes enriched in zone III vs. I contained a different
subset of transcripts including Dmp1 and Mmp13, which we had
identified in a previous study [29] and/or confirmed with qRTPCR analysis. Bone transcripts were enriched in zone II and zone
III, respectively, when compared to zone I. Core genes found in
these groups included Bmp7, parathyroid hormone receptor 1
(Pthr1), Tnfsf11, and Ibsp, which are prototypical markers of EO
(Table S1–7, S3–12, see supplemental data) [60].
While many of the expected functional classifications and
markers were expressed, genes used to calculate the enrichment
scores of the significantly enriched gene sets were not necessarily
known cartilage markers. It is therefore likely that the differences
we observe in the different growth plate regions could be a
function of network connections rather than only its individual
constituents. This reinforces the concept that key zone-specific
regulatory molecules are supported by the expression of numerous
other molecular players. It is interesting to note that the cartilage
gene set taken from another published microarray screen failed to
be significantly enriched in our growth plate comparisons [23].
This observation likely highlights the effect of experimental
methods on gene expression. In addition to species (mouse vs.
rat) and age (i.e. fetal vs. adolescent) differences, the actual
processing of the cells used for gene expression analysis differed. In
our study, total RNA was directly isolated from tibiae while
Wang’s study, which used laser-capture microdissection of rat
growth plates, involved cryogenic sectioning before expression
analysis [23].
These analyses suggest that zones I and III show well defined
enrichment patterns and consequently zone-specific expression.
Gene expression in zone II seems less distinct, which is consistent
with the transitions chondrocytes must undergo to presage bone
deposition. Additional studies that address the precise gene
expression differences in the transition regions between zones I
vs. II and II vs. III of the tibia are necessary to more accurately
define the markers expressed as chondrocytes terminally differentiate.

Figure 4. Gene ontology annotations of microdissected growth
plate zone comparisons. Lists of probe sets subject to pair-wise
comparisons between zones I and zone II (I vs. II), zone II and zone III (II
vs. III) and zone I and zone III (I vs. III) were each classified according to
biological process (BP), cellular component (CC), and molecular function
(MF) (A). The most significant hierarchy was followed in each case until
the smallest significant sub-classification was found. In each list,
developmental (DEV), collagen (COL) and transporter functions
(TRANSF) were identified. P-values less than 0.001 were deemed
significant in each case. The number of probe sets both common to
each respective zone comparison and unique to a given list was
illustrated using a Venn diagram (B).
doi:10.1371/journal.pone.0008693.g004

other preset gene sets, for example gene sets corresponding to tissuespecific gene expression or specific functional categories [34]. We
compared the expression of genes found in zone I to genes expressed
in zones II and III, and finally between zone II and zone III. We
then compared these lists to a matrix of 90 user-defined gene sets
(Table 3) belonging to various molecular classifications (see methods
for details). Significantly enriched classes had p-values less than
0.001 and maximum FDR of 25%. Gene sets corresponding to
ECM, growth factors, angiogenic factors and chemokines were all
enriched in zone I when compared to zone II (Table S1-1–9, see
supplemental data). Gene sets were also made from analogous
comparisons between different stages of the chondrocyte development in micromass cultures (MM) [29]. These gene sets were
enriched in our analysis, which supported the suitability of primary
cell culture models in studying gene expression in chondrocytes.
Enrichment of the user-defined gene sets in zone II, however, was
limited since the only significant gene set contained genes associated
with chaperone activity (Table S1–6, see supplemental data). Zone
II gene sets that met the FDR cutoff, but not the p-value cutoff,
included phosphatases, metabolic molecules, genes involved in
TGFb signaling and bone markers.
PLoS ONE | www.plosone.org

Comparisons between Micromass and Microdissected
Data Sets
Next, we wanted to determine whether the genes expressed in
the microdissected embryonic tibiae were comparable to our
previously used micromass (MM) culture system [29]. Based on
established knowledge of gene expression in the MM system, we
matched pair-wise comparisons between the three microdissected
(MD) growth plate zones to pair-wise comparisons between
8
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different MM culture days. Only those comparisons that
demonstrated the largest similarity between both experiments
were selected for further analysis. Differential expression between
days 3 and 9 of MM culture was likened to zone I vs. II
comparison; day 9 vs. 15 of MM culture was analogous to zone II
vs. III comparison and day 3 vs. 15 of MM culture was compared
to zone I vs. III. The first phase of our analysis involved
determining whether genes differentially expressed in the MD data
set were similarly expressed in the MM data set.
We first compared the number of probe sets significantly
expressed in either the MM or MD data sets and found 11 806
common probe sets, 1 379 probe sets found only in the MM data
set and 10 691 probe sets found only in the MD data set
(Figure 5A). Since we were comparing probe sets from two
different array platforms, namely the MOE 430A (MM) and MOE
430 2.0 (MD) chips, the former of which contains half the probe
sets of the latter, we anticipated and confirmed that approximately
50% of probe sets from the MD data would match corresponding
probes in the MM data set. Also, it is likely that day 3 of MM
culture represents a slightly earlier stage of chondrocyte development compared to MD zone I. The discrepancy between day 3 of
MM and zone I of the growth plate could additionally be due to

the fact that MM are derived from the mesenchyme which has the
potential to develop into numerous cell types (of myogenic,
adipogenic and osteogenic lineages) and is therefore a heterogeneous cell population, whereas zone I is mostly constituted of
chondrocytes.
The next phase of the analysis involved comparing our MM
time point comparisons to our MD zone comparisons (Figure 5B).
In this case, approximately 40% of transcripts were common
between MM and MD data set using the MM values and 20%
when using the MD numbers. However, it is apparent that the
majority of the genes identified in the pair-wise comparisons were
not shared between MM and MD.
Therefore, we asked whether the most significantly changed
genes were common between the MM and MD data. Only 15 of
the 100 most significantly changed genes were similar between the
experimental systems (Figure 6 and 7).

Figure 5. Genes expressed in both microdissected embryonic
tibiae and primary mesenchymal micromass cultures. Venn
diagrams delineating the overlap between probe sets expressed in the
microdissected (MD) tibiae array data set and the micromass (MM) array
data set (A). Pair-wise comparisons between individual growth plate
zones are compared to their similar pair-wise comparisons in the
micromass culture data (B). Specifically, probe sets differentially
expressed between days 3 and 9 (3 vs. 9) of micromass culture are
compared to the I vs. II list. Similarly, probe sets differentially expressed
between days 9 and 15 (9 vs. 15) and days 3 and 15 (3 vs. 15) of
micromass culture are compared to probes identified in II vs. III and
zone I vs. III lists, respectively.
doi:10.1371/journal.pone.0008693.g005

PLoS ONE | www.plosone.org

Figure 6. Similarities between the micromass culture time
course and microdissected growth plate data sets. Heat maps of
genes exhibiting highest differential expression and positive correlations to either zones I or II in the pair-wise microdissection comparisons
are shown. Signal intensities are illustrated by varying shades of red
(up-regulation) and blue (down-regulation). Arrows indicate genes
common to the corresponding micromass comparisons.
doi:10.1371/journal.pone.0008693.g006
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days could be different from our tibia zones. We aimed to further
corroborate these findings by analyzing both data sets by GSEA in
parallel. We used a series of gene sets from the Molecular
Signature Database that contains genes grouped based on
chromosomal region (c1), pathways (c2) and common motifs
(c3). In cases where the interrogated gene list had a FDR that was
above the 25% cutoff, we selected the top 20 gene sets for
comparison.

c1 Comparisons
To obtain an objective view of the similarities and differences
between the MM and MD data sets, we decided to look at several
molecular categories. The first was cytogenetic loci, corresponding
to the c1 gene set matrix from MgSigDB. Specifically, we
compared the NES scores assigned to each cytogenetic locus that
was correlated with a particular time point or growth plate zone
comparison. We compared MM day 3 vs. 9 to MD zone I vs. II
data and identified 6 enriched cytogenetic locations (Table S4–1,2,
see supplemental data). In all cases except for one (Table S4–1,2),
days 3 vs. 9 and zones I vs. II were similarly enriched.
Another emerging pattern included enrichment in day 9 and
zone II (Table S4–3,4) and correlated with loci associated with
skeleton-related chromosome mutations and genetic determinants
related to the bone phenotype [61–65]. The 9 vs. 15, II vs. III
comparisons show a total of 10 enriched gene sets, all but one of
which showed the expected similar enrichment pattern (Table S4–
3,4, see supplemental data). Other loci enriched at day 9 and zone
II or day 15 and zone III were similar in their association with
bone-related loci [66–71]. Four main enrichment patterns
occurred in the day 3 vs. 15 and zone I vs. III comparison (Table
S4–6). Two chromosomal gene sets,deviated from the expected
trend in the day 3 vs. 15 and zone I vs. III comparison (Table S4–
6). This pattern appeared to be counter-intuitive since day 3 and
zone III represent two opposite stages in the chondrocyte life cycle,
but it could be explained by the fact that both loci are linked to the
skeleton. [72,73]. In addition, three loci exhibited common
enrichment in day 3 and zone I, and the remaining seven gene
sets were enriched in day 15 and zone III. These gene sets were
also linked to the skeleton [49,74–76]. Therefore, in most cases,
enrichment patterns for different cytogenetic loci are conserved;
however, the relationship between the identified loci and the
individual genes making up the probe sets belonging to MM and
MD data sets are not congruent.

c2 Comparisons
We next evaluated similarities and differences in overrepresented biological pathways using the c2 gene set matrix,
describing pathways. Compared to the c1 data set, fewer gene sets
were similarly enriched in MM and MD comparisons. Three of
four gene sets (proteasome, electron transport and oxidative
phosphorylation pathways) were enriched for day 3 (compared to
day 9) and zone II (compared to zone I) (Table S5–1,2, see
supplemental data). Only two categories were similarly enriched
between the MM and MD data sets in the 9 vs. 15, II vs. III
comparisons. They belonged to the fatty acid and cytokine
categories, both of which help modulate developmental processes
by inhibiting chondrocyte hypertrophy and promoting prostaglandin synthesis [77–79]. The remaining 15 gene sets exhibited
different enrichment patterns that, with the exception of the
proteasome pathway (which was similarly enriched in zone III and
day 9), showed similar enrichment in zone II and day 15 of MM
culture (Table S5–3,4, see supplemental data). Thus, in both cases
the enrichment patterns did not show the expected similarities
between the MM AND MD data sets.

Figure 7. Heat map of micromass culture data set analyzed by
GSEA. GSEA-derived heat maps of the top 100 differentially expressed
probe sets enriched in micromass data. Correlations between probe
sets and day 3 or day 9 of micromass culture for the first map, day 9 or
day 15 for the second map and day 3 or day 15 for the third map are
shown. Expression profiles for all experimental replicates are depicted
for each time point. Signal intensities are illustrated by varying shades
of red (up-regulation) and blue (down-regulation). Arrows indicate
genes common to the corresponding microdissected growth plate zone
comparisons.
doi:10.1371/journal.pone.0008693.g007

We postulated that these results could reflect the limitations of
inter-array comparisons and nuances in the way each experiment
was executed. However, our previous analysis (in which gene lists
derived from the MM array were enriched in the MD data set)
suggests that these comparisons did not reflect the full extent of the
similarities between both data sets. These analyses did, however,
point to the fact that on the level of individual genes, with the
exception of prototypical chondrocyte markers, our MM culture
PLoS ONE | www.plosone.org
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role of endoplasmatic reticulum (ER) stress and unfolded protein
response (UPR) in connective tissue diseases and particularly in
chondrodysplasias. For example, ER stress was elevated in
hypertrophic chondrocytes in a mouse model of metaphyseal
chondrodysplasia type Schmid (MCDS) [80], folding of COMP
was abnormal in pseudoachondroplasia and multiple epiphyseal
dysplasia [81,82] and Bbf2h7 (an ER-resident transcription factor)
KO mice showed severe chondrodysplasia with abnormal
proliferative and hypertrophic zones [83]. These recent data show
the importance of proper folding of secreted proteins – and by
extension a role of chaperone proteins asisting with protein folding
- in cartilage development. The enrichement of chaperone gene
expression in the prehypertrophic/hypertrophic zone II of the
growth plate makes this category a very exciting new pathway to
investigate in cartilage development and particulalry in hypertrophic chondrocyte differentiation.
In addition, this study compared gene expression in micromass
cultures, an in vitro model to study chondrocyte differentiation,
with gene expression in growing endochondral bones in vivo.
Parallel analysis in which gene expression in the MD array was
compared to the MM array showed that while cytogenetic loci,
some pathways and most motifs showed similar changes in the
different models of chondrocyte development, individual markers
exhibiting the largest gene expression changes in each data set
were poorly conserved, with the exception of well known matrix
markers and a few other genes. Pathway analysis also
demonstrated limited similarities between MM and MD data
sets, with the best fit for gene set correlated with day 15 and zone
III and categories involved in angiogenesis and matrix remodeling.
While the micromass culture system is able to recapitulate
expression of the major markers of chondrocyte gene expression,
subtle, physiologically relevant differences could be overlooked in
this model. Feasibility however, dictates that cell culture models
are still an important means of evaluating cartilage gene
expression. The challenge will be to design these models in a
way in which the integrity of the tissue can be preserved, to
quantify limitations in the models and, where possible, to make the
transition to in vivo systems.

The day 3 vs. 15 and zone I vs. III fit best with our predictions
for high similarity between the MM and MD data sets. All three
gene sets showed correlation with day 15 MM and zone III of
the tibia (Table S5–5,6, see supplemental data). The three gene
sets represented in this comparison included the T-cell differentiation pathway, matrix metalloproteinases and reactive oxygen
species.
These data indicate that there are some major gene expression
differences between these experimental models. In addition,
conservation between the MM day 3 vs. 9 and the MD zones I
vs. II gene lists was poor. The day 9 vs. 15 and zone II vs. III
pathways showed the highest similarity between day 15 of MM
and zone II of MD, opposite to expectations. This result
implicates enriched pathways in both hypertrophy and mineralization, which is not inconceivable, since these processes closely
follow each other temporally. The observed enrichment pattern
suggests that the ability of micromass cultures to recapitulate
normal biological pathways is limited. The potential effects of
enzymatic digestion, which disrupts and re-establishes the cellcell and cell-matrix interactions in culture may account for this
finding. Additionally, the inherent cellular heterogeneity persisting in the later stage chondrocyte cultures may be responsible for
the apparent correlation between day 15 and zone II of MD.
Specifically, chondrocytes in the centers of the micromass
cultures and immature cells lining the periphery of the cartilage
nodules even after 15 days of culture might additionally be
responsible for this effect. Altogether these data suggest that the
experimental system used may have a significant bearing on
resolution of gene expression between different zones of the
growth plate and also the biological pathways regulated in
cartilage.

c3 Comparisons
We next evaluated the similarities between the c3 data set that
incorporates information about different documented regulatory
motifs. The 3 vs. 9, I vs. II comparison identified 11 gene sets that
were enriched on day 3 of MM and in zone I of MD, as expected
(Table S6–1,2, see supplemental data). Five gene sets showed
enrichment in day 3 of MM and zone II of MD. The remaining 4
gene sets were enriched in day 9 of MM and zone I of MD. All
gene sets in the 9 vs. 15, II vs. III comparisons yielded similar gene
sets between the two experimental methods. Eight gene sets were
enriched in day 9 of MM and zone II of MD, while the other 12
were enriched at day 15 of MM and in zone III of the MD (Table
S6–3,4, see supplemental data). In the final comparison between
day 3 vs. 15 and zone I vs. III, 6 gene sets were enriched in day 3
of MM and zone I of the growth plate, 10 gene sets were enriched
in day 15 of MM and zone III in the MD and 4 gene sets showed
the opposing enrichment in day 3 MM and zone III of MD (Table
S6–5,6, see supplemental data). Overall, regulatory motifs were
well conserved between the MM and MD data sets, which could
ideally provide clues into the identity of important chondrocyte
regulatory molecules.
In conclusion, this study evaluates gene expression changes
between three different zones of a growing tibia. Gene Ontology
annotations show that similar functional categories are being
modulated throughout chondrocyte maturation, namely genes
related to development, ECM and transporter activity. GSEA
enrichment of user-defined gene sets yielded several functional
categories including ECM, growth factors, angiogenesis, chemokines and matrix metalloproteinases.
Interestingly, the ‘‘chaperone activity’’ category was enriched in
the prehypertrophic/hypertrophic zone II when compared either
with zone I or zone III. Recent studies have been investigated the
PLoS ONE | www.plosone.org
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